Immune cell BDNF secretion is associated with white matter volume in multiple sclerosis

Journal of Neuroimmunology

Volumn 188, Issue 1-2, 2007, Pages 167-174

  Weinstock Guttman, Bianca ^a   Zivadinov, Robert ^a,b   Tamaño Blanco, Miriam ^c   Abdelrahman, Nadir ^b   Badgett, Darlene ^c   Durfee, Jackie ^b   Hussein, Sara ^b   Feichter, Joan ^a   Patrick, Kara ^a   Benedict, Ralph ^a   Ramanathan, Murali ^a,c  

^a BUFFALO GENERAL HOSPITAL   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

BDNF; Magnetic resonance imaging; Multiple sclerosis; Neurotrophic factors; Pharmacogenetics

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CD3 ANTIBODY;

ADULT; ANALYTIC METHOD; ARTICLE; CELL REGENERATION; CENTRAL NERVOUS SYSTEM; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; GRAY MATTER; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NERVE CELL; NERVE CELL GROWTH; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; WHITE MATTER;

ADULT; ANTIBODIES; ANTIGENS, CD; BRAIN-DERIVED NEUROTROPHIC FACTOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INTERFERON-BETA; MAGNETIC RESONANCE IMAGING; MALE; METHIONINE; MIDDLE AGED; MONOCYTES; MULTIPLE SCLEROSIS; VALINE;

EID: 34547117420     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.06.003     Document Type: Article

References (29)

1. Barkhof F., Bruck W., De Groot C.J., Bergers E., Hulshof S., Geurts J., Polman C.H., and van der Valk P. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch. Neurol. 60 (2003) 1073-1081
2. Benedict R.H., Bruce J.M., Dwyer M.G., Abdelrahman N., Hussein S., Weinstock-Guttman B., Garg N., Munschauer F., and Zivadinov R. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. Arch. Neurol. 63 (2006) 1301-1306
3. Chang A., Nishiyama A., Peterson J., Prineas J., and Trapp B.D. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J. Neurosci. 20 (2000) 6404-6412
4. Chen Z.Y., Patel P.D., Sant G., Meng C.X., Teng K.K., Hempstead B.L., and Lee F.S. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J. Neurosci. 24 (2004) 4401-4411
5. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15 532-534 (1993) 536-537
6. Chomczynski P., and Mackey K. Short technical reports. Modification of the TRI reagent procedure for isolation of RNA from polysaccharide- and proteoglycan-rich sources. Biotechniques 19 (1995) 942-945
7. Deloire-Grassin M.S., Brochet B., Quesson B., Delalande C., Dousset V., Canioni P., and Petry K.G. In vivo evaluation of remyelination in rat brain by magnetization transfer imaging. J. Neurol. Sci. 178 (2000) 10-16
8. Dousset V., Degreze P., Mieze S., Sesay M., Basse-Cathalinat B., and Caille J.M. Magnetization transfer on in vitro circulating blood: implications for time-of-flight MR angiography. J. Magn. Reson. Imaging 5 (1995) 786-788
9. Dowling P., Ming X., Raval S., Husar W., Casaccia-Bonnefil P., Chao M., Cook S., and Blumberg B. Up-regulated p75NTR neurotrophin receptor on glial cells in MS plaques. Neurology 53 (1999) 1676-1682
10. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., and Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 (2003) 257-269
11. Gielen A., Khademi M., Muhallab S., Olsson T., and Piehl F. Increased brain-derived neurotrophic factor expression in white blood cells of relapsing-remitting multiple sclerosis patients. Scand. J. Immunol. 57 (2003) 493-497
12. Hohlfeld R., Kerschensteiner M., Stadelmann C., Lassmann H., and Wekerle H. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. J. Neuroimmunol. 107 (2000) 161-166
13. Jenkinson M., Bannister P., Brady M., and Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage 17 (2002) 825-841
14. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E., Kolbeck R., Hoppe E., Oropeza-Wekerle R.L., Bartke I., Stadelmann C., Lassmann H., Wekerle H., and Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?. J. Exp. Med. 189 (1999) 865-870
15. Li D.K., Held U., Petkau J., Daumer M., Barkhof F., Fazekas F., Frank J.A., Kappos L., Miller D.H., Simon J.H., Wolinsky J.S., and Filippi M. MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability. Neurology 66 (2006) 1384-1389
16. Lu B., and Gottschalk W. Modulation of hippocampal synaptic transmission and plasticity by neurotrophins. Prog. Brain Res. 128 (2000) 231-241
17. Pezawas L., Verchinski B.A., Mattay V.S., Callicott J.H., Kolachana B.S., Straub R.E., Egan M.F., Meyer-Lindenberg A., and Weinberger D.R. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J. Neurosci. 24 (2004) 10099-10102
18. Poo M.M. Neurotrophins as synaptic modulators. Nat. Rev., Neurosci. 2 (2001) 24-32
19. Sarchielli P., Greco L., Stipa A., Floridi A., and Gallai V. Brain-derived neurotrophic factor in patients with multiple sclerosis. J. Neuroimmunol. 132 (2002) 180-188
20. Sarchielli P., Zaffaroni M., Floridi A., Greco L., Candeliere A., Mattioni A., Tenaglia S., Di Filippo M., and Calabresi P. Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-{beta} 1a, and high doses of immunoglobulins. Mult. Scler. 13 (2007) 313-331
21. Schmierer K., Scaravilli F., Altmann D.R., Barker G.J., and Miller D.H. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann. Neurol. 56 (2004) 407-415
22. Smith S.M., De Stefano N., Jenkinson M., and Matthews P.M. Normalized accurate measurement of longitudinal brain change. J. Comput. Assist. Tomogr. 25 (2001) 466-475
23. Smith S.M., Zhang Y., Jenkinson M., Chen J., Matthews P.M., Federico A., and De Stefano N. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. NeuroImage 17 (2002) 479-489
24. Stadelmann C., Kerschensteiner M., Misgeld T., Bruck W., Hohlfeld R., and Lassmann H. BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?. Brain 125 (2002) 75-85
25. Tavazzi E., Dwyer M.G., Weinstock-Guttman B., Lema J., Bastianello S., Bergamaschi R., Cosi V., Benedict R.H., Munschauer III F.E., and Zivadinov R. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis. Neuroimage 36 (2007) 746-754
26. Tjoa C.W., Dwyer M.G., Hussein S., and Zivadinov R. Brain segmentation inconsistency significantly impacts magnetisation transfer measures. Mult. Scler. 11 (2005) S147 P562., S147 P562
27. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., and Bo L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338 (1998) 278-285
28. Trapp B.D., Ransohoff R., and Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr. Opin. Neurol. 12 (1999) 295-302
29. Zivadinov R., Dwyer M., and Watt K.L. Measurement of cerebral grey and white matter atrophy measurement from various MRI pulse sequences using different segmentation algorithms. J. Neurol. 251 (2004) S89